CV UPDATED SEP 2016

of 14
Yosra S.R.Elnaggar CV
Curriculum Vitae
Yosra S.R. Elnaggar, Ph.D.
Personal Data
Name: Yosra Shaaban Rabea Elnaggar
Gender: Female
Date of Birth: January 9, 1982
Citizenship: EGYPT
Contact: Tel: 002 01277629944
002 01147591065
Email: yosra_pharm@yahoo.com
yosra.elnaggar@pua.edu.eg
Address: 18 Masged Elhedaya St.,
Alexandria, Egypt
 Google Scholar account:
https://scholar.google.dk/citations?user=chHQ6I0AAAAJ&hl=da
 H-Index (9)
 Scopus Author ID: 30867539100 http://orcid.org/0000-0002-6939-7777
 Orchid Author ID: orcid.org/0000-0002-6939-7777 https://orcid.org/my-orcid
Work Experience
1- 1 February 2016-Present: Associate Professor of Pharmaceutics; Faculty of
Pharmacy and drug manufacturing; Pharos University in Alexandria.
2- 29 December 2015- 30 January 2015: Associate Professor of Pharmaceutics,
Faculty of Pharmacy, Alexandria University, Egypt.
3- 25 September 2010 – 28 December 2015: Lecturer of Pharmaceutics,
4- August 2012-January 2013: Director of Central Laboratory at Faculty of
Pharmacy, Alexandria University, Egypt.
5- 21 August 2007 – 24 September 2010: Assistant Lecturer of Pharmaceutics,
6- 5 January 2005 – 20 August 2007: Demonstrator of Pharmaceutics, Faculty
of Pharmacy, Alexandria University, Egypt.
Education
1- Ph.D. in Pharmaceutical Sciences, Pharmaceutics, Alexandria University, Egypt,
2010.
Thesis Title: "Development and Evaluation of Some New Disperse Drug Delivery
Systems Using Nanotechnology"
2- M.Sc. in Pharmaceutical Sciences, Pharmaceutics, Alexandria University, Egypt,
2007. Thesis Title: “Development and Evaluation o Selected Oral Dosage Forms”

of 14
3- Bachelor of Pharmaceutical sciences “Distinction, Honor”, Alexandria
University, Egypt, 2004.
Teaching Experience
Teaching Topic Course content University Academic
program/Level
1. Pharmacy
orientation
(Introduction to
pharmacy)
-Information resources
-Code of ethics /
heritage of pharmacy
-Routes of
administration
-Pharmacy careers,
organizations
-
Alexandria
University
Clinical Pharmacy
program, first year
(Credit hour system).
2. Physical pharmacy -State of matter
-Phases and Phase
transitions; - Colloids
- Aerosols
Alexandria
University
Classical Pharmacy
program, first year
3.Sterile dosage
forms
-Parenteral products
-Ophthalmic dosage
forms
-
Alexandria
university
- Damanhur
university
- Pharos
University
of
Alexandria
(PUA)
-Classical pharmacy
program, second year
(Credit hour system)
4.Semisolid dosage
forms
-Cream, Ointment and
gels
-Damanhur
University
Classical Pharmacy
program, second year
5.Pharmaceutical
dosage forms -2
Parenteral products Alexandria
University
Clinical pharmacy
program third year
6. Hospital pharmacy -Parenteral infusions
- IV admixtures
- IV incompatibilities
-
Heamodialysis/peritone
al dialysis
- Peritoneal irrigation
- Radiopharmaceuticals
- Medical gases
-Blood substitutes and
Pharos
University
in
Alexandria
(PUA)
Hospital pharmacy
program, Fourth year
students

of 14
Plasma expanders
7. Special course for
postgraduate master
and PhD students
-Seminar course on
selected topics :Lipid
based delivery systems,
self-emulsifying
formulations, liposomes
and modified
generations, delivery
systems for
phytopharmaceuticals,
chronotherapy and
validation in industry
- Seminar course for
PhD degree students
Alexandria
University
-Postgraduate master
students
-PhD students
8. Clinical pharmacy Introduction and bases
for clinical pharmacy;
pharmaceutical care
compartments; evidence
based medicine; taking
medication history;
smoking-drug
interaction; food-drug
interaction; SOAP and
FARM notes;
interferences of
laboratory data;
medication errors;
medical health
problems.
Pharos
University
in
Alexandria
PUA
5th year students
9. History and Ethics in
Pharmacy Practice
Ethics in pharmacy
practice
Ethics in research
(plagiarism)
Academic integrity for
undergraduate students
Pharos
University
in
Alexandria
PUA
Freshmen students
(Spring 2016)
10. Bachelor
Graduation Project
Nanotechnology in
cancer therapy)
Pharos
University
in
Alexandria
PUA
Senior 5th year
students (spring
2016)_

of 14
Industrial Trainings
Completed the Pharmaceutical Manufacturing Practicing Program (PMPP), 80 training
hours, in Amria Pharmaceutical Industry, 2003.
Language qualifications
English Fluent (National TOEFL score 587 out of 680)
Arabic: Mother tongue.
Awards
24 November 2015: Received Alexandria University Award for Scientific
Motivation for the year 2015.
Awards for international publications
1- Alexandria University Award for publication in top 20 % of pharmacy and
pharmacology journal rank (red jasper, 2009): International Journal of
Pharmaceutics 380 (1-2): 133-141 (2009).
2- Alexandria University Award for publication in top 50 % of Nanotechnology
journal rank (ISI, 2011): International Journal of Nanotechnology 8 (8-9):
749-763 (2011).
pharmacology and nanotechnology journal rank (ISI): International journal of
nanomedicine 2011:6 3195–3205 (2011).
pharmacology and nanotechnology journal rank (ISI): International journal of
nanomedicine 2012:7 3787–3802 (2012).
pharmacology and nanotechnology journal rank (ISI): International Journal
of Nanomedicine 2013:8 2385–2397 (2013)
pharmacology and nanotechnology journal rank (ISI): International journal
of Pharmaceutics. 454 : 462– 471 (2013)
7- Pharos University of Alexandria (PUA) award for publication in top 5 % of
pharmacy and pharmacology ISI journal rank : Journal of Controlled Release
180 : 10–24 (2014).
8- Alexandria University award for publication in top 5 % of pharmacy and
pharmacology ISI journal rank : Journal of Controlled Release 180 : 10–24
(2014)
pharmacology journal rank (ISI): Journal of Controlled Release 194: 92–
102(2014)
10- Alexandria University Award for publication in top 20 % of pharmacy
and pharmacology journal rank (ISI): International journal of pharmaceutics
(486): 588-98 (2015).

of 14
11- Pharos University of Alexandria (PUA) Award for publication in top 20
% of pharmacy and pharmacology ISI journal rank International journal of
pharmaceutics (486): 588-98 (2015)
and pharmacology journal rank (ISI): Pharmaceutical Research 32:2901–2911
(2015)
and pharmacology journal rank (ISI): Journal of Pharmaceutical Sciences.
104:3544–3556, (2015)
and pharmacology and nanotechnology journal rank (ISI): International
Journal of Nanomedicine 10 5459–5473 (2015)
15-
Author Nominations
1- Nominated as “Favorite Author” in the International Journal of
Nanomedicine favorite author reward program, January 2012
2- Nominated to be included in Marquiz Who's Who in the World list, 2012
(29th Edition).
Special Carrier Development Training courses (workshops)
1. FLDC workshops (Faculty Leadership Development Center); Alexandria
University)
Course Name
# of training
days
Certified by
1. Effective Teaching (April 2007)
Threedaysfivehoursperdayeach
InternationalBoardofCertified
Trainers-EuropeanDivision(IBCT)
2. Research Methodology (April 2007)
3. Effective Communication Skills (April
2007)
4. Thinking Skills (May 2007)
5. Code of Ethics (December 2007)
6. Teaching with Technology (January
2008)
7. Quality Standards in Teaching (January
2008)

of 14
8. International Publishing of Scientific
Research (June 2010)
9. Legal and Financial Aspects in
University Environment (June 2010).
10.Preparing Research Project (July 2010)
11.Reference Management Programs
(Endnote) August 2014
Twodayssixhourspereachday
12.Decision Making and Problem Solving
Workshop (August 2014)
13.Student Evaluation and Assessment
Techniques (August 2014)
14.Effective Presentation Skills (March
2015)
15.Management of Crisis and Disaster
(April 2015)
16. Credit Hour System (May 2015)
2. EDC-CPD workshops at Pharos University in Alexandria (PUA)
Workshop Name Date
1. Academic integrity
1-10 February 2016
2. Student's assessment
3. Learning styles
4. Motivation strategies and feed back
5. Interactive learning
6. Syllabus design and construction
7. Managing lectures
Community and Students Services
 December 2012- Present: Head of Alamal student’s social group, Faculty of
Pharmacy, Alexandria University, Egypt.
 September 2012-to present: Member in student affairs and learning committee.
September 2012-to present: Member in testing committee for selection of eligible
students to visit Koyoto Pharmaceutical University (Japan)
 September 2012-to present: Member in faculty committee for students with
special academic support

of 14
Speaker in Workshops, Conferences and Presentations
1. Oral disintegrating tablets: Recent advances and premises; (7/7/2007); Faculty of
Pharmacy, Alexandria University.
2. Lipid based delivery systems for oral delivery: biopharmaceutical challenges and
regulatory status (25/5/2008) Faculty of Pharmacy, Alexandria University.
3. Self-nanoemulsifying drug delivery systems: Recent review (2/8/2010) Faculty of
Pharmacy, Alexandria University.
4. Phytosomes as Nanomedicines for Enhanced Diosmin Delivery. An oral
Presentation at the Annual conference of Alexandria University Held at Faculty of
Medicine, Alexandria University Egypt (27-28 / 12/2012).
5. International Publications and H-index: Towards higher PUA international ranking;
Pharos University in Alexandria (PUA); (9/ 2016)
Research interest
Nanomedicine and pharmaceutical nanotechnology as an imperative tool to
improve therapeutic efficacy of drugs mainly in cancer therapy. I have a good
experience in elaboration and appraisal procedures of Lipid nanocarriers, polymeric
nanoparticles and drug nanosuspensions. Nanomedicines of interest encompass nano-
sized delivery systems including Solid Lipid Nanoparticles (SLN), Nanostructured
Lipid Carriers (NLC), Nanoemulsion, Self-nanoemulsifying Drug Delivery Systems
(SNEDDS), Liposomes, Self-emulsifying phospholipid dispersions, Phytosomes,
Bilosomes, transfersomes, ethosomes, Hylauossomes, polymersomes. Nano-structured
gels and chitosan nanoparticles. My experience in optimization and assessment of
delivery systems covers different non-invasive routes of administration including oral,
sublingual, intranasal, and dermal and transdermal routes of administration, with
detailed hands on experience in in-vitro transdermal studies via human and animal
skin modeling, Alzheimer,s animal model and cancer cell line techniques. Recent
delivery approaches focused on cancer and disease targeting via both passive and
active techniques, with higher emphasis on herbal drugs. Another important approach
is employment of bioactive nanocarriers to improve bioavailability of drugs suffering
pre-systemic clearance. Furthermore, research interest encompasses pharmaceutical
technology with higher concern in Orally Disintegrating Tablets (ODT);
manufacturing; evaluation and patents.
Projects
Title
Development of potential vaccine candidates against Schistosoma mansoni using novel
delivery systems
Date Role Funding Agency
2010-
2011
Co
Investigator
Enhancement Program (ALEX REP); Alexandria, Egypt.

of 14
International Peer review
Peer reviewer in the following highly ranked international journals in
pharmaceutics:
1. International Journal of Pharmaceutics (November 2009).
2. Drug Development and Industrial Pharmacy (February 2010).
3. Current Drug Delivery (March 2010).
4. Recent Patents in Drug Delivery and Formulation (May 2010)
5. European Journal of Pharmaceutical Sciences (January 2011).
6. Journal of Nanoparticle Research (May 2011)
7. International Journal of Nanomedicines (July 2011)
8. Pharmaceutical research (January 2012).
9. European Journal of Pharmaceutics and Biopharmaceutics (May 2012)
10.DARU Journal of Pharmaceutical Sciences (March 2013)
11.Drug Delivery letters ( April 2013)
12.Artificial cells, NANOMEDICINE and Biotechnology (May 2016)
Supervising thesis
1. Nanocarriers as Promising Approach in Pharmaceutical Products Development
(Master thesis, registered October 2010, Defended August 2012).
2. A novel drug delivery approach for optimization of the pharmaceutical quality of
herbal drugs (Master thesis, registered October 2010, Defended May 2013)
3. Self-emulsifying lipid dispersion: an approach to improve delivery characteristics
of some poorly-soluble phytopharmaceuticals (Master thesis , registered
September 2011)
4. Preparation and Evaluation of gel microemulsions and lipogels to enhance the
efficacy of poorly permeable drugs (Master thesis, registered September 2011).
5. Design and characterization of some modified vesicular systems as nano-metric
drug carriers (Master thesis, registered November 2012)
6. Development of selected nano-structured systems for modulation of dermal and
transdermal drug delivery. (PhD thesis, registered January 2013, defended
February 2015)
7. Employment of Cell Culture technique in Development and Assessment of
Selected Drug Delivery Systems (PhD thesis, registered July 2013)
8. Design and Characterization of Selected Nanomedicines for Improving Drug
Efficacy in Alzheimer's disease Therapy (master thesis, registered July 2013;
defended March 2015)
9. Development and evaluation of novel nano-systems for targeted cancer therapy,
(PhD thesis, registered March 2014)
10.Preparation and Evaluation of Polymerosomes versus Lipid Vesicles for
Improved Drug Delivery (Master thesis, registered September 2014).
11.Design and Characterization of Lipid-Polymer Hybrid Nanoparticles for
Optimization of Drug Delivery. (Master thesis, registered October 2014).

of 14
12.Development and Appraisal of Gel-core Liposomes Improved Delivery of Selected
Drugs (Master thesis, registered April 2015)
Workshops and conferences
1. Participant in "Nanotechnology Advances" conference (November 2008);
Science college, University of Alexandria, Egypt.
2. Participant in Workshop on characterization of nanoparticles using
dynamic light scattering; Malvern cooperation, material characterization
(October 2010) faculty of pharmacy, Alexandria, Egypt
3. Participant in Workshop on different methods of students, evaluation and
cognitive domains (October 2010), Faculty of Pharmacy; University of
Alexandria, Egypt.
4. Participant in Workshop on construction of written, oral and practical
examinations (December 2010); Faculty of Pharmacy; University of
Alexandria, Egypt.
5. Participant in Workshop on e-learning: electronic and curricula of faculties
of pharmacy in different universities (November 2010), Faculty of Pharmacy;
University of Alexandria, Egypt.
6. Participating by a poster and abstract in the FUE international conference on
pharmaceutical technologies held in February 2012 at the Intercontinental
city star, Future University, Cairo, Egypt.
7. Supervisor and organizer of the student scientific forum “Recent Advances in
Pharmacy: Nanotechnology and Pharmacy Practice” held by pharmacy
students on 31st March to 2 April 2012 at faculty of pharmacy, Alexandria
University, Egypt.
8. Participant in BioVisionAlexandria2012 Conference: New life science:
Linking Science to Society, held at Bibliotheca Alexandria 22nd -25th April
2012.
9. Participant in the Annual Conference of Pharmaceutics Department held in
faculty of pharmacy, Alexandria University 4/9/2012.
10.Attendee in a lecture on "Interpretation of clinical laboratory data: part I"
given on 4 November 2012 at Faculty of Pharmacy Alexandria University, Egypt.
11.Speaker and Participant by abstract in Annual Conference of Alexandria
University held in Faculty of Medicine, Alexandria University 27th-28th
December 2012.
12.Participated by published abstract in abstract in 5th international conference
on drug discovery and therapy 5th ICDDT; February 18th-21st 2013, Dubai,
UAE.
13.Participant in Research day for Pharmacy graduates, February, 22, 2014, faculty
of pharmacy, Alexandria University, Egypt.
14.Poster presentation in 3rd FUE International Conference of Pharmaceutical
Sciences (3rd FUE-ICPS) held in February 2012 at the Intercontinental city star,
Future University, Cairo, Egypt February 9-11, 2015.

of 14
15.Poster presentation in 6th International Congress BioNanoMed 2015 -
Nanotechnology enables Personalized Medicine held in Graz, Austria from
8 – 10 April (2015)
16.Poster presentation in First PUA International Conference on Advances in
Pharmaceutical Sciences (ICAPS) held in Pharos University of Alexandria 27-
28 October 2015).
17.Attendee in PUA field project discussion ceremony of bachelor students
PUA (17 February 2016)
18.Reviewer to the poster session in BioVisionAlexandria 2016: New life
sciences: The Road Ahead held in bibliotheca Alexandria 12-14 April
2016.
19.Workshop on Interactive learning and its technique. Faculty of pharmacy
and drug manufacturing. Pharos University of Alexandria 1 March 2016
20.Attendee in Annual Scientific day of pharmaceutics Department. Faculty of
pharmacy and drug manufacturing. Pharos University of Alexandria 15
March 2016
21.Attendee in Orientation workshop to Fulbright program. Faculty of
Engineering. Pharos University of Alexandria. 22 March 2016
22.Attendee in Annual Scientific day of Faculty of pharmacy and drug
manufacturing-PUA 26 April 2016
23.Supervisor of Graduation project presentation on Implementations of
nanomedicine in cancer therapy Faculty of pharmacy and drug
manufacturing. Pharos University of Alexandria 4 May 2015
24.Supervisor on student posters in Pharmacist day of Faculty of pharmacy and
drug manufacturing-Pharos University in Alexandria 5 May 2016.
25.Attendee in Ceremony of faculty of Pharmacy and drug manufacturing, Pharos University
in Alexandria for Accreditation. 10 May 2016.
26.Attendee in Graduation project presentation on recent brain tumor therapy
Faculty of pharmacy and drug manufacturing-Pharos University in Alexandria
17 May 2016.
Membership in Faculty committees
1. 2012-to present: Member in student affairs and learning committee
2. 2012-2013/ 2013-2014: Member of testing committee for selection of eligible
students to visit Koyoto Pharmaceutical University (Japan)
3. 2013-2014: Department representative member in Library committee
4. 2013-2014: Member in Faculty committee of students with special needs
5. 2013-present: Member in quality assurance committee of pharmaceutics
department
6. 2016-2017: Head of Scientific Research Sector; Quality Assurance Unit, Pharos
University in Alexandria.

of 14
List of International publications:
1. Yosra. S.R. Elnaggar*, Magda. A. El-Massik, Ossama. Y. Abdallah. Self-nanoemulsifying
drug delivery systems of tamoxifen citrate: Design and optimization. International
Journal of Pharmaceutics 380 (1-2): 133-141 (2009).
http://dx.doi.org/10.1504/IJNT.2011.041443
http://www.scopus.com/inward/record.url?eid=2-s2.0-
79960803950&partnerID=MN8TOARS
2. Yosra S.R. Elnaggar*, Magda A. El-Massik, Ossama Y. Abdallah,and Abd Elazim R. Ebian.
Maltodextrin: A Novel Excipient Used in Sugar-Based Orally Disintegrating Tablets and
Phase Transition Process. AAPS PharmSciTech. 11(2): 645-651 (2010).
http://dx.doi.org/10.1208/s12249-010-9423-y
3. Yosra. S.R. Elnaggar*, Magda. A. El-Massik, Ossama. Y. Abdallah. Sildenafil Citrate
Nanoemulsion versus Self-nanoemulsifying Delivery Systems: Rationale Development and
Transdermal Permeation. International Journal of Nanotechnology 8 (8-9): 749-763
(2011) {Selected for the release media of that special issue dedicated to nanomedicine].
http://dx.doi.org/10.1504/IJNT.2011.041443
4. Yosra. S.R. Elnaggar*, Magda. A. El-Massik, Ossama. Y. Abdallah. Fabrication, Appraisal,
and Transdermal Permeation of Sildenafil Citrate Loaded Nano-structured Lipid Carriers
versus Solid Lipid Nanoparticles. International Journal of Nanomedicine 6: 3195–3205
(2011). http://www.scopus.com/inward/record.url?eid=2-s2.0-
5. Manal A. Elsheikh*, Yosra S.R. Elnaggar, Eman Y. Gohar , Ossama Y.Abdallah . Impact of
Nanomedicine on the In-vitro and In-vivo Characteristics of Raloxifene Hydrochloride. An
abstract and poster presentation in the FUA International Conference on
Pharmaceutical Technologies, Future University, Cairo, Egypt (9-11 February 2012).
6. Manal A. Elsheikh, Yosra S.R. Elnaggar*, Eman Y. Gohar, Ossama Y.Abdallah.
Nanoemulsion Liquid-preconcentartes for Raloxifene Hydrochloride: Optimization and In-
vivo Appraisal. International Journal of Nanomedicine, 7: 3787–3802 (2012).
http://dx.doi.org/10.2147/IJN.S33186
7. Yosra S.R.Elnaggar1*, May S. Freag1, Ossama Y. Abdallah1. Optimization and Ex-vivo
Permeation of Phytosomes as Platforms for Improved Diosmin Delivery. Published
abstract in 5th international conference on drug discovery and therapy (5th ICDDT);
Dubai, UAE 18-21 February (2013).
8. May S. Freag1, Yosra S.R.Elnaggar1*, Ossama Y. Abdallah. Lyophilized Phytosomal
Nanocarriers (LPNs) as Platforms for Enhanced Diosmin Delivery: Optimization and Ex-

of 14
vivo Permeation. International Journal of Nanomedicine 8: 2385–2397 (2013).
http://dx.doi.org/10.2147/IJN.S45231.
9. May S. Freag1, Yosra S.R.Elnaggar1*, Ossama Y. Abdallah. Development of Novel Polymer-
stabilized Diosmin Nanosuspensions: In-vitro Appraisal and Ex-vivo permeation
International journal of Pharmaceutics. 454: 462– 471 (2013).
http://dx.doi.org/10.1016/j.ijpharm.2013.06.039
10.Yosra S.R. Elnaggara*, Wessam M. El-Refaieb, Magda A. El-Massikb, Ossama Y. Abdallaha.
Lecithin-based nanostructured gels for skin delivery: An update on state of art and recent
applications. Journal of Controlled Release 180: 10–24 (2014).
http://dx.doi.org/10.1016/j.jconrel.2014.02.004
11.Manal A. Elsheikh , Yosra S.R. Elnaggar ,*, Ossama Y. Abdallah . Rationale employment of
cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers.
Journal of Controlled Release 194: 92–102 (2014).
http://dx.doi.org/10.1016/j.jconrel.2014.08.019
12.Eman MM Shehata, Yosra SR Elnaggar, Saly Galal, Ossama Y Abdallah. Enhanced
dissolution and intestinal permeation of genistein from bioactive self-emulsifying
phospholipid dispersion (SEPD). An abstract and poster presentation in the 3rd FUE
International Conference of Pharmaceutical Sciences (3rd FUE-ICPS). Future
University, Cairo, Egypt: 9-11 February (2015).
13.Samar M. Etman (1a), Yosra S.R. Elnaggar (1b), Doaa A. Abdelmonsif (2)*, Ossama Y.
Abdallah (1c). Brain-Targeted Piperine-loaded Chitosan Nanoparticles: A novel era in
Alzheimer's Therapy. 6th International Congress BioNanoMed 2015 - Nanotechnology
enables Personalized Medicine, held in Graz, Austria from 8 – 10 April (2015).
14. Wessam M. El-Refaieb, Yosra S.R. Elnaggara*, Magda A. El-Massikb, Ossama Y.
Abdallaha.Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of
Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation. Pharmaceutical
Research 32:2901–2911 (2015). http://dx.doi.org/10.1007/s11095-015-1672-8
15.Yosra S.R. Elnaggara*. Multifaceted implementations of bile salts in pharmacy: An
emphasis on nanomedicine. International Journal of Nanomedicine 10:3955-3971
(2015). http://dx.doi.org/10.2147/IJN.S82558

of 14
16.Wessam M. El-Refaiea, Yosra S.R. Elnaggarb*, Magda A. El-Massika, Ossama Y. Abdallahb.
Novel Curcumin-loaded Gel-Core Hyaluosomes with Promising Burn-Wound Healing
Potential: Development, In-vitro Appraisal and In-vivo Studies. International journal of
pharmaceutics 486: 588-98 (2015). http://dx.doi.org/10.1016/j.ijpharm.2015.03.052
17.Yosra S.R. Elnaggara*, Samar M. Etmana ,Doaa A. Abdelmonsif b, Ossama Y. Abdallaha.
Optimization and In-vivo Appraisal of Piperine-loaded Intranasal Chitosan Nanoparticles
as Brain-Targeted Dual Acting Therapy in Alzheimer's disease. Journal of
Pharmaceutical Sciences. 104:3544–3556, 2015). http://dx.doi.org/10.1002/jps.24557
18. Yosra S.R. Elnaggara*, Samar M. Etmana ,Doaa A. Abdelmonsif b, Ossama Y.
Abdallaha.Novel Piperine-loaded Tween-integrated Monooleain Cubosomes as Brain-
targeted Oral Nanomedicine in Alzheimer's disease: Pharmaceutical, Biological and
Toxicological Studies. International Journal of Nanomedicine: 10 5459–5473 (2015).
http://dx.doi.org/10.2147%2FIJN.S87336
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556290/
19. Sara M. Talaat, YosraS.R. Elnaggar, OssamaY. Abdallah. Novel Lecithin-Microemulsion
Based Gels (LMBGs) for Targeted Dermal Delivery of Terconazole: Optimization,
Microbiological and Permeation Studies. Poster presentation in First PUA International
Conference on Advances in Pharmaceutical Sciences (ICAPS) held in Pharos University of
Alexandria 27-28 October 2015).
20. Eman M.M. Shehataa, Yosra S.R. Elnaggara,b,*, Saly Galala, Ossama Y. Abdallah. Self-
emulsifying phospholipid pre-concentrates (SEPPs) for improved oral delivery of the anti-
cancer genistein: Development, appraisal and ex-vivo intestinal permeation. International
Journal of Pharmaceutics 511 (2016) 745–756.
http://dx.doi.org/10.1016/j.ijpharm.2016.07.078
21. May S. Freag1
, Yosra S.R.Elnaggar1, 2*
, Doaa A. Abdelmonsif 3
, Ossama Y. Abdallah1
.
Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced
aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. International Journal
of Nanomedicine 2016:11 1–20
22. May S. Freag1
, Yosra S.R.Elnaggar1, 2*
, Doaa A. Abdelmonsif 3
Layer
-by- Layer coated Lyotropic Liquid crystalline nanoparticles for Active Tumor Targeting
of Rapamycin. Nanomedicine. (Accepted for publication 25 August 2016).
23. Sara M. Talaata Yosra S.R. Elnaggar Mohammed Bahey-El-Dinc . Ossama Y. Abdallaha
Novel Lecithin-integrated Liquid Crystalline Nanogels for Enhanced Cutaneous Targeting of
Terconazole: Development, In-vitro and In-vivo Studies. International Journal of
Nanomedicine. Accepted for publication 16 August 2016.
24. Yosra S.R.Elnaggar1, 2
, Eman MM Shehata 1*
, Saly Galal 1
. Self-
emulsifying Pre-concentrates of Daidzein-Phospholipid Complex for Bioavailability

of 14
Enhancement: Optimization, In-vitro characterization and Pharmacokinetics . European
Journal of Pharmaceutics and Biopharmaceutics Manuscript under review. Sept.2016
25. Manal A Elsheikh1,2
, Yosra S.R. Elnaggar 1,3*
, Elsayeda Zeinab Abdelfattah 4
, Hoda Khalifa 5
,
Ossama Y. Abdallah1
. “Development of Novel Orthotopic Liver Tumor Mouse Model Using
Ehrlich Ascites Carcinoma Cell Line”. European Journal of Cancer. Manuscript under review.
Sept.2016

CV UPDATED SEP 2016

More Related Content

What's hot

Viewers also liked

CV UPDATED SEP 2016